20:35 , Feb 3, 2017 |  BC Week In Review  |  Company News

Scancell, Bonnie J. Addario Lung Cancer Foundation, Addario Lung Cancer Medical Institute deal

Scancell and the nonprofits partnered to conduct a Phase I/II trial of Scancell's SCIB2 in patients with non-small cell lung cancer (NSCLC). The trial will start in 2018 and will be completed about 18 months...
07:00 , Aug 18, 2014 |  BC Week In Review  |  Clinical News

FoundationOne: Clinical trial started

Foundation Medicine said The Addario Lung Cancer Medical Institute (ALCMI) and Bonnie J. Addario Lung Cancer Foundation (ALCF) will use the company’s FoundationOne assay in the international Genomics of Young Lung Cancer study in about...